My Macmillan

Publication Details

Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm
Zoledronic acid for primary breast cancer

Zoledronic acid for primary breast cancer (April 2019)

Zoledronic acid is a drug that’s given to reduce the risk of breast cancer spreading to the bones and other parts of the body. This booklet explains what it is, who might be offered it and the side effects it can cause.

Author(s)
Breast Cancer Care
Place of publication
London
Publisher
Date of publication
April 2019
Pages
12pp
Edition
1st edition
Price
Free. Postage charged on large orders.
Order reference
Format
Booklet
Language
English
Flesch readability score
65.6
Download this resource
Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm